Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aurora Cannabis (TSE:ACB)
TSX:ACB
Holding TSE:ACB?
Track your performance easily
See the Price Targets and Ratings of:
ACB Analyst Ratings
Hold
0 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ACB Stock 12 Month Forecast
Average Price Target
C$8.01
▲(32.99% Upside)
| Highest Price TargetC$8.00 | Average Price TargetC$8.01 | Lowest Price TargetC$8.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Roth MKM
Reiterated
11/07/24
Canaccord Genuity
C$9→C$10
Buy
66.11%
Upside
Reiterated
08/08/24
Aurora Cannabis (ACB:CN) (ACB) PT Raised to Cdn$10 at Canaccord GenuityCanaccord Genuity analyst Matt Bottomley raised the price target on Aurora Cannabis (ACB:CN) (NASDAQ: ACB) to Cdn$10.00 (from Cdn$9.00) while maintaining a Buy rating.
Zuanic and Associates
―
Hold
―
Initiated
06/27/24
Zuanic and Associates starts Aurora Cannabis (ACB) at NeutralZuanic and Associates analyst Pablo Zuanic initiates coverage on Aurora Cannabis (NASDAQ: ACB) with a Neutral rating.
ATB Capital Markets
C$12.5→C$11
Hold
82.72%
Upside
Reiterated
06/21/24
Fridays analyst upgrades and downgrades for June 21, 2024 - The Globe and MailAdj. EBITDA of $1.9-million fell from $4.3-million last quarter, with the sequential decline mostly driven by i) the revenue miss and ii) adj. SGA of $31.6-million (which excludes business transformation costs, non-recurring costs and out-of-period adjustments totalling $8.6-milion) coming in above managements $30-million target due to incremental costs associated with the integration of MedReleaf Australia, he said.
Jefferies
C$4.95
Hold
-17.77%
Downside
Reiterated
02/26/24
Analysts Have Conflicting Sentiments on These Healthcare Companies: CSL (Other OTC: CMXHF), Aurora Cannabis (NASDAQ: ACB) and SI-Bone (NASDAQ: SIBN)
Scotiabank
C$8→C$6
Hold
-0.33%
Downside
Reiterated
02/21/24
CIBC Sticks to Their Hold Rating for Aurora Cannabis (ACB)
Best Analysts Covering Aurora Cannabis
Which Analyst Should I Follow If I Want to Buy TSE:ACB and Sell After:
1 Month
xxx
Success Rate
7/17 ratings generated profit
Average Return
-1.07%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 41.18% of your transactions generating a profit, with an average return of -1.07% per trade.
3 Months
xxx
Success Rate
11/17 ratings generated profit
Average Return
+7.36%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 64.71% of your transactions generating a profit, with an average return of +7.36% per trade.
1 Year
Success Rate
8/17 ratings generated profit
Average Return
-5.81%
reiterated a buy rating 4 months ago
Copying Matt Bottomley's trades and holding each position for 1 Year would result in 47.06% of your transactions generating a profit, with an average return of -5.81% per trade.
2 Years
xxx
Success Rate
6/17 ratings generated profit
Average Return
-19.92%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 35.29% of your transactions generating a profit, with an average return of -19.92% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ACB Analyst Recommendation Trends
Rating
Jan 24
Feb 24
Jun 24
Aug 24
Nov 24
Strong Buy
0
1
2
2
1
Buy
0
0
0
1
1
Hold
8
8
6
6
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
8
9
8
9
7
Each month's total comprises the sum of three months' worth of ratings.
ACB Financial Forecast
ACB Stock Forecast FAQ
What is TSE:ACB’s average 12-month price target, according to analysts?
Based on analyst ratings, Aurora Cannabis’s 12-month average price target is C$8.01.
What is TSE:ACB’s upside potential, based on the analysts’ average price target?
Aurora Cannabis has 32.99% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is TSE:ACB a Buy, Sell or Hold?
Aurora Cannabis has a consensus rating of Hold which is based on 0 buy ratings, 1 hold ratings and 0 sell ratings.
What is Aurora Cannabis’s price target?
The average price target for Aurora Cannabis is C$8.01. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is C$8.00 ,the lowest forecast is C$8.00. The average price target represents 32.99% Increase from the current price of C$6.02.
The highest analyst price target is C$8.00 ,the lowest forecast is C$8.00. The average price target represents 32.99% Increase from the current price of C$6.02.
What do analysts say about Aurora Cannabis?
Aurora Cannabis’s analyst rating consensus is a Hold. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of TSE:ACB?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.